Blau Syndrome, the prototypic auto-inflammatory granulomatous disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jabs DA, Houk JL, Bias WB, Arnett FC: Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985, 78: 801-804.
Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP: CARD15 mutations in Blau syndrome. Nat Genet. 2001, 29: 19-20.
Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y: Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Dermatol. 2004, 122: 851-852.
Rose CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, Martin TM: Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol. 2005, 32: 373-375.
Rose CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, Martin TM: Pediatric granulomatous arthritis: an international registry. Arthritis Rheum. 2006, 54: 3337-3344.
Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, Desmet VJ, Fischer A, Roskams T, Wouters CH: Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. 2012, 129: 1076-1084.
Rose CD, Cimaz R, Thomee C, Khubchandani RP, Espada G, Russo R, Harjacek M, Bader Meunier B, Brissaud P, Wulffraat N, Vastert S, Merino R, Naranjo-Hernandez A, Oliveira-Knupp S, Mackensen F, Arostegui J, Anton J, Fernandez-Martin J, Wouters C: Blau Prospective Cohort Study: Articular and Ocular Outcomes. 2013, Lausanne, Switzerland: 17th Congress of ISSAID, International Society of Systemic Auto-Inflammatory Diseases
Arostegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, Garcia-Consuegra J, Naranjo A, Ramos E, de Paz P, Ruis J, Plaza S, Yagüe J: NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007, 56: 3805-3813.
Hafner R, Vogel P: Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol. 1993, 11: 685-691.
North AF, Fink CW, Gibson WM, Levinson JE, Schuchter SL, Howard WK, Johnson NH, Harris C: Sarcoid arthritis in children. Am J Med. 1970, 48: 449-455.
Pastores GM, Michels VV, Stickler GB, Su WP, Nelson AM, Bovenmyer DA: Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts. J Pediatr. 1990, 117: 403-408.
Raphael SA, Blau EB, Zhang WH, Hsu SH: Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am J Dis Child. 1993, 147: 842-848.
Rose CD, Martin TM: Caspase recruitment domain 15 mutations and rheumatic diseases. Curr Opin Rheumatol. 2005, 17: 579-585.
Stoevesandt J, Morbach H, Martin TM, Zierhut M, Girschick H, Hamm H: Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol. 2010, 27: 69-73.
Lindsley CB, Godfrey WA: Childhood sarcoidosis manifesting as juvenile rheumatoid arthritis. Pediatrics. 1985, 76: 765-768.
Rose CD, Arostegui JI, Martin TM, Espada G, Scalzi L, Yague J, Rosenbaum JT, Modesto C, Cristina Arnal M, Merino R, García-Consuegra J, Carballo Silva MA, Wouters CH: NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009, 60: 1797-1803.
Gross KR, Malleson PN, Culham G, Lirenman DS, McCormick AQ, Petty RE: Vasculopathy with renal artery stenosis in a child with sarcoidosis. J Pediatr. 1986, 108: 724-726.
Rose CD, Eichenfield AH, Goldsmith DP, Athreya BH: Early onset sarcoidosis with aortitis–“juvenile systemic granulomatosis?”. J Rheumatol. 1990, 17: 102-106.
Rotenstein D, Gibbas DL, Majmudar B, Chastain EA: Familial granulomatous arteritis with polyarthritis of juvenile onset. N Engl J Med. 1982, 306: 86-90.
Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, Inohara N, Nunez G, Tromp G, Williams CJ: CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002, 46: 3041-3045.
Khubchandani RP, Hasija R, Touitou I, Khemani C, Wouters CH, Rose CD: Blau arteritis resembling Takayasu disease with a novel NOD2 mutation. J Rheumatol. 2012, 39: 1888-1892.
Nia AE, Nabavi M, Nasab MM: Central nervous system involvement in Blau syndrome: a new feature of the syndrome?. J Rheumatol. 2007, 34: 2504-2505.
Becker ML, Martin TM, Doyle TM, Rose CD: Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum. 2007, 56: 1292-1294.
Meiorin SM, Espada G, Costa CE, Tartara A, De Matteo E, Wouters C, Martin TM, Rose CD: Granulomatous nephritis associated with R334Q mutation in NOD2. J Rheumatol. 2007, 34: 1945-1947.
Ting SS, Ziegler J, Fischer E: Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr. 1998, 133: 450-452.
Saini SK, Rose CD: Liver involvement in familial granulomatous arthritis (Blau syndrome). J Rheumatol. 1996, 23: 396-399.
Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, Cimaz R: Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013, 65: 513-518.
Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y: Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005, 105: 1195-1197.
Milman N, Ursin K, Rodevand E, Nielsen FC, Hansen TV: A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members. Scand J Rheumatol. 2009, 38: 190-197.
Okada S, Konishi N, Tsumura M, Shirao K, Yasunaga S, Sakai H, Nishikomori R, Takihara Y, Kobayashi M: Cardiac infiltration in early-onset sarcoidosis associated with a novel heterozygous mutation, G481D, in CARD15. Rheumatology. 2009, 48: 706-707.
Priori R, Bombardieri M, Spinelli FR, Merlin F, Miceli-Richard C, La Cava M, Scavalli AS, Guerrisi R, Hugot JP, Valesini G: Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with lifelong follow-up. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 228-231.
Sakai H, Ito S, Nishikomori R, Takaoka Y, Kawai T, Saito M, Okafuji I, Yasumi T, Heike T, Nakahata T: A case of early-onset sarcoidosis with a six-base deletion in the NOD2 gene. Rheumatology. 2010, 49: 194-196.
van Duist MM, Albrecht M, Podswiadek M, Giachino D, Lengauer T, Punzi L, De Marchi M: A new CARD15 mutation in Blau syndrome. Eur J Hum Genet. 2005, 13: 742-747.
Villanueva-Mendoza C, Arellanes-Garcia L, Cubas-Lorenzo V, Jimenez-Martinez MC, Flores-Suarez LF, Zenteno JC: Familial case of Blau syndrome associated with a CARD15/NOD2 mutation. Ophthalmic Genet. 2010, 31: 155-158.
Infevers Registry. [fmf.igh.cnrs.fr/infevers]
Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T: Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009, 60: 242-250.
Saulsbury FT, Wouters CH, Martin TM, Austin CR, Doyle TM, Goodwin KA, Rose CD: Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009, 60: 1804-1806.
Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C: Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011, 66: 144-150.
van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC: Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007, 27: 660-669.
Zhong Y, Kinio A, Saleh M: Functions of NOD-like receptors in human diseases. Front Immunol. 2013, 16: 333-
Jun JC, Cominelli F, Abbott DW: RIP2 activity in inflammatory diseases and implications for novel therapeutics. J Leukoc Biol. 2013, 94: 927-932.
Shaw MH, Reimer T, Sanchez-Valdepenas C, Warner N, Kim YG, Fresno M, Nunez G: T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat Immunol. 2009, 10: 1267-1274.
Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S: Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009, 10: 1073-1080.
Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Yuan L, Soares F, Chea E, Le Bourhis L, Boneca IG, Allaoui A, Jones NL, Nuñez G, Girardin SE, Philpott DJ: Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010, 11: 55-62.
Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G: Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003, 100: 3455-3460.
Aksentijevich I, D Putnam C, Remmers EF, Mueller JL, Le J, Kolodner RD, Moak Z, Chuang M, Austin F, Goldbach-Mansky R, Hoffman HM, Kastner DL: The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007, 56: 1273-1285.
Martin TM, Zhang Z, Kurz P, Rose CD, Chen H, Lu H, Planck SR, Davey MP, Rosenbaum JT: The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum. 2009, 60: 611-618.